DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,383 | +0.5% | 66,032 | -2.8% | 1.45% | +5.0% |
| Q2 2023 | $16,303 | -7.7% | 67,930 | -3.0% | 1.38% | -13.9% |
| Q1 2023 | $17,657 | -16.9% | 70,054 | -12.5% | 1.61% | -20.4% |
| Q4 2022 | $21,250 | -99.9% | 80,060 | -7.6% | 2.02% | -10.9% |
| Q3 2022 | $22,374,000 | +2.0% | 86,623 | +0.2% | 2.27% | +9.3% |
| Q2 2022 | $21,926,000 | -14.5% | 86,486 | -1.0% | 2.07% | +0.2% |
| Q1 2022 | $25,637,000 | -10.5% | 87,399 | +0.4% | 2.07% | -4.5% |
| Q4 2021 | $28,652,000 | +5.9% | 87,084 | -2.0% | 2.17% | -5.7% |
| Q3 2021 | $27,056,000 | +6.7% | 88,873 | -5.9% | 2.30% | +7.2% |
| Q2 2021 | $25,355,000 | +12.2% | 94,482 | -5.9% | 2.14% | +2.1% |
| Q1 2021 | $22,605,000 | -3.5% | 100,431 | -4.8% | 2.10% | -7.8% |
| Q4 2020 | $23,431,000 | -2.7% | 105,481 | -5.7% | 2.28% | -12.2% |
| Q3 2020 | $24,090,000 | +20.3% | 111,874 | -1.2% | 2.59% | +9.0% |
| Q2 2020 | $20,033,000 | +25.1% | 113,289 | -2.1% | 2.38% | +2.0% |
| Q1 2020 | $16,010,000 | -19.0% | 115,674 | -10.2% | 2.33% | -0.3% |
| Q4 2019 | $19,763,000 | +6.5% | 128,766 | +0.2% | 2.34% | -0.2% |
| Q3 2019 | $18,561,000 | +1.4% | 128,512 | +0.3% | 2.34% | -0.6% |
| Q2 2019 | $18,311,000 | +9.3% | 128,117 | +0.9% | 2.36% | +1.0% |
| Q1 2019 | $16,756,000 | +6.4% | 126,923 | -16.9% | 2.33% | -6.3% |
| Q4 2018 | $15,741,000 | -6.5% | 152,650 | -1.5% | 2.49% | +9.3% |
| Q3 2018 | $16,832,000 | +43.0% | 154,905 | +29.9% | 2.28% | +32.7% |
| Q2 2018 | $11,768,000 | +23.5% | 119,256 | +22.5% | 1.72% | +20.2% |
| Q1 2018 | $9,529,000 | -7.6% | 97,320 | -12.4% | 1.43% | -7.4% |
| Q4 2017 | $10,313,000 | +6.9% | 111,110 | -1.2% | 1.54% | -2.5% |
| Q3 2017 | $9,646,000 | -8.4% | 112,445 | -9.9% | 1.58% | -12.1% |
| Q2 2017 | $10,532,000 | -0.4% | 124,800 | +0.9% | 1.80% | -3.5% |
| Q1 2017 | $10,578,000 | +9.5% | 123,680 | -0.3% | 1.87% | +9.6% |
| Q4 2016 | $9,656,000 | +42.9% | 124,050 | +43.9% | 1.70% | +38.6% |
| Q3 2016 | $6,757,000 | -23.8% | 86,195 | -1.8% | 1.23% | -26.9% |
| Q2 2016 | $8,864,000 | +60.4% | 87,758 | +50.6% | 1.68% | +54.0% |
| Q1 2016 | $5,527,000 | -15.6% | 58,260 | -17.4% | 1.09% | -15.2% |
| Q4 2015 | $6,549,000 | +4.6% | 70,515 | -4.1% | 1.29% | +3.7% |
| Q3 2015 | $6,263,000 | -0.4% | 73,495 | 0.0% | 1.24% | +10.3% |
| Q2 2015 | $6,290,000 | -6.2% | 73,495 | -7.0% | 1.13% | -8.3% |
| Q1 2015 | $6,708,000 | -3.5% | 79,008 | -2.5% | 1.23% | -7.1% |
| Q4 2014 | $6,948,000 | +0.9% | 81,063 | -10.6% | 1.32% | +1.0% |
| Q3 2014 | $6,886,000 | -4.5% | 90,628 | -1.1% | 1.31% | -5.0% |
| Q2 2014 | $7,214,000 | +23.3% | 91,628 | +17.4% | 1.38% | +17.6% |
| Q1 2014 | $5,852,000 | +0.5% | 78,023 | +3.5% | 1.17% | -0.3% |
| Q4 2013 | $5,821,000 | +29.1% | 75,408 | +15.9% | 1.18% | +16.2% |
| Q3 2013 | $4,509,000 | +113.9% | 65,052 | +95.3% | 1.01% | +95.7% |
| Q2 2013 | $2,108,000 | – | 33,305 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |